Treatment progress of mantle cell lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 572-576, 2021.
Artículo
en Chino
| WPRIM
| ID: wpr-907217
ABSTRACT
Mantle cell lymphoma is a B-cell malignancy with unique biological, pathological and clinical characteristics, accounting for about 5%-10% of non-Hodgkin lymphoma (NHL), and most patients are diagnosed at advanced stage. Mantle cell lymphoma has the aggressive characteristic of aggressive lymphoma and the refractory characteristic of indolent lymphoma, and the prognosis of patients is poor. In recent years, with the development of high-dose chemotherapy, autologous hematopoietic stem cell transplantation and new drug research, the survival time of patients has been significantly prolonged.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio pronóstico
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS